You are here

bempegaldesleukin

BMS and Nektar Shutter Combination Cancer Development Program

BioSpace

Fri, 04/15/22 - 01:42 pm

Bristol Myers Squibb

Nektar Therapeutics

renal cell carcinoma

bempegaldesleukin

Nektar Left Reassessing After Canceled Melanoma Trials

BioSpace

Tue, 03/15/22 - 11:38 pm

Bristol Myers Squibb

clinical trials

bempegaldesleukin

BMS-Nektar's Opdivo combo fails phase 3 in upset to once-largest licensing deal in biotech history

Fierce Biotech

Mon, 03/14/22 - 10:24 am

Bristol Myers Squibb

Nektar Therapeutics

bempegaldesleukin

clinical trials

Propel fails to propel Nektar

EP Vantage

Mon, 11/8/21 - 10:48 am

Nektar Therapeutics

bempegaldesleukin

clinical trials

metastatic non-small cell lung cancer

Immuno-oncology combination for melanoma using Nektar drug boosts cell therapy in mice

Fierce Biotech

Fri, 01/31/20 - 12:11 pm

Nektar Therapeutics

bempegaldesleukin